Biblio Discovery — Demo Discovery Service

11 results for "Line Nederby"

Showing 1–11 · 0.06 seconds · RSS

  1. Journal Article

    High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens

    Katrine Fladeland Iversen; Line Nederby; Thomas Lund et al.

    Clinical Hematology International, Vol. 4 No. 3 · 2022 · English · DOAJ Scopus

    Abstract Multiple myeloma is an incurable disease characterized by unregulated growth of malignant plasma cells in the bone marrow (BM). Tumor-induced dysfunction of T-cells may be responsible for immune evasion and failure of immunotherapy. Therefore, a better understanding of the phenotype of…

  2. Journal Article

    A novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemia

    Marie Toft-Petersen; Eigil Kjeldsen; Line Nederby et al.

    Leukemia Research Reports, Vol. 3 No. 2 · 2014 · English · DOAJ Scopus

    We have identified a novel 7.7 Mb del(8)(q23.2q24.11) in a patient progressing to acute myeloid leukemia (AML) following a 12-year stable phase of chronic myelomonocytic leukemia (CMML). A surprisingly high JAK2+ allelic burden of 92% at the time of AML led us to delineate the molecular aberrations…

  3. Journal Article

    Sensitive ligand-based protein quantification using immuno-PCR: A critical review of single-probe and proximity ligation assays

    Marcus Celik Hansen; Line Nederby; Mads Okkels-Birk Henriksen et al.

    BioTechniques, Vol. 56 No. 5 · 2014 · English · DOAJ Scopus

    Quantitative PCR (qPCR) of reverse-transcribed mRNA has revolutionized gene expression analyses. qPCR analysis is based on the prevalent assumption that mRNA transcript numbers provide an adequate measure of specific biomarker expression. However, taking the complexity of protein turnover into…

  4. Journal Article

    Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research

    Marcus Celik Hansen; Line Nederby; Anne Roug et al.

    MethodsX, Vol. 2 No. C · 2015 · English · DOAJ Scopus

    …at hand. In brief, post-processing is performed by: • Mapping of germ line and somatic variants to coding regions, and defining variant sets within Mathematica. • Processing of variants in variant effect predictor. • Extended annotation, relevance scoring and defining focus areas through the…

  5. Journal Article

    Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy

    Jon Røikjær Henriksen; Line Nederby; Frede Donskov et al.

    Journal of Ovarian Research, Vol. 13 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Purpose Biomarkers are needed to guide treatment decisions in recurrent ovarian cancer, as a high proportion of patients do not benefit from treatments. Data on immune subsets in patients receiving chemotherapy are scarce. We investigated the impact of T cells, B cells, neutrophils and the…

  6. Journal Article

    Natural killer cell activity in prostate cancer patients treated with curative radiotherapy with or without androgen deprivation therapy: an observational study

    Stine V. Eriksen; Christine V. Madsen; Signe Timm et al.

    Acta Oncologica, Vol. 64 · 2025 · English · DOAJ Scopus

    Background and purpose: Natural killer (NK) cells play an important role in defense against cancer. Low NK cell activity (NKA) has been linked to prostate cancer (PCa) detection, and effective NKA may be associated with better prognosis in metastatic PCa. Radiotherapy (RT) could affect the immune…

  7. Journal Article

    Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients

    Morten Borg; Sara Witting Christensen Wen; Torben Frøstrup Hansen et al.

    Journal of International Medical Research, Vol. 50 · 2022 · English · DOAJ Scopus

    Objective Natural killer (NK) cells play an essential role in the immune response against cancer. However, immune escape mechanisms may cause inferior NK cell activity (NKA) in patients with cancer. This prospective study examined the relationship between NKA and lung cancer in a high-risk cohort…

  8. Journal Article

    Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy

    Sinne Søberg Brun; Torben Frøstrup Hansen; Sara Witting Christensen Wen et al.

    Scientific Reports, Vol. 14 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Many studies have focused on the prognostic role of soluble programmed death ligand 1 (sPD-L1) in non-small cell lung cancer (NSCLC), but outcomes are ambiguous and further investigations are needed. We addressed the matter by studying sPD-L1 in baseline samples and in longitudinal samples…

  9. Journal Article

    Prognostic performance of a novel multiplex circulating tumor DNA assay for lung cancer outcomes

    Peter Hjorth-Hansen; Line Nederby; Cecilie Mondrup Jacobsen et al.

    Therapeutic Advances in Medical Oncology, Vol. 18 · 2026 · English · DOAJ Scopus

    Background: Lung cancer is a heterogeneous disease with unpredictable trajectories. Risk stratification in lung cancer remains imprecise within tumor-node-metastasis (TNM) stages. Objectives: This work aims to evaluate whether methylated circulating tumor DNA (ctDNA) can improve prognostication at…

  10. Journal Article

    Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer

    Torben Frøstrup Hansen; Line Nederby; Ahmed H. Zedan et al.

    Translational Oncology, Vol. 12 No. 7 · 2019 · English · DOAJ Scopus

    INTRODUCTION: The aim of the present study was to analyze the possible correlation between Natural Killer (NK) cell activity as measured by the NK Vue assay and treatment efficacy in patients with disseminated cancer. MATERIALS AND METHODS: The study included four trials encompassing palliative…

  11. Journal Article

    Description of an activity-based enzyme biosensor for lung cancer detection

    Paul W. Dempsey; Cristina-Mihaela Sandu; Ricardo Gonzalezirias et al.

    Communications Medicine, Vol. 4 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background Lung cancer is associated with the greatest cancer mortality as it typically presents with incurable distributed disease. Biomarkers relevant to risk assessment for the detection of lung cancer continue to be a challenge because they are often not detectable during the…